Arrowgrass Capital Partners (US)’s Array Biopharma Inc ARRY Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-369,800	Closed	-$17.1M	–	350
2019 Q2	$17.1M	Buy	+369,800	New	+$10.4M	0.41%	69

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s ARRY Position: Q3 2019 in Review

Arrowgrass Capital Partners (US) sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 369,800 shares — an estimated $17.1M sold.

Arrowgrass Capital Partners (US) first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $17.1M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Arrowgrass Capital Partners (US) reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Arrowgrass Capital Partners (US) sold 369,800 Array Biopharma Inc shares in Q3 2019, an estimated $17.1M.
Arrowgrass Capital Partners (US) first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
Arrowgrass Capital Partners (US)'s Array Biopharma Inc position peaked at $17.1M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2019, filed 14 Nov 2019.